Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakers

Heart Rhythm

Volumn 11, Issue 12, 2014, Pages 2214-2221

  Gonzalez, Maday ^a   Keating, Richard J ^a   Markowitz, Steven M ^a   Liu, Christopher F ^a   Thomas, George ^a   Ip, James E ^a   Lerman, Bruce B ^a   Cheung, Jim W ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Atrial fibrillation; Mortality; Permanent pacemaker

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; WARFARIN;

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIAL HIGH RATE EPISODE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DUAL CHAMBER PACEMAKER; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATIONAL DEATH INDEX; OUTCOME ASSESSMENT; PACEMAKER IMPLANTATION; RATING SCALE; TREND STUDY; VERY ELDERLY; ADVERSE EFFECTS; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; ELECTROCARDIOGRAPHY; EMBOLISM; HEART PACING; KAPLAN MEIER METHOD; MORTALITY; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL; TIME; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; CAUSE OF DEATH; COHORT STUDIES; ELECTROCARDIOGRAPHY; EMBOLISM; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACEMAKER, ARTIFICIAL; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84919462538     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2014.08.019     Document Type: Article

References (26)

1. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, and D.E. Singer Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
2. D.M. Lloyd-Jones, T.J. Wang, E.P. Leip, M.G. Larson, D. Levy, R.S. Vasan, R.B. D'Agostino, J.M. Massaro, A. Beiser, P.A. Wolf, and E.J. Benjamin Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046
3. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham Study Stroke 22 1991 983 988
4. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
5. R.S. Passman, K.M. Weinberg, M. Freher, P. Denes, A. Schaechter, J.J. Goldberger, and A.H. Kadish Accuracy of mode switch algorithms for detection of atrial tachyarrhythmias J Cardiovasc Electrophysiol 15 2004 773 777
6. P. Defaye, F. Dournaux, and E. Mouton Prevalence of supraventricular arrhythmias from the automated analysis of data stored in the DDD pacemakers of 617 patients: the AIDA study. The AIDA Multicenter Study Group. Automatic Interpretation for Diagnosis Assistance Pacing Clin Electrophysiol 21 1998 250 255
7. J.W. Cheung, R.J. Keating, K.M. Stein, S.M. Markowitz, S. Iwai, B.K. Shah, B.B. Lerman, and S. Mittal Newly detected atrial fibrillation following dual chamber pacemaker implantation J Cardiovasc Electrophysiol 17 2006 1323 1328
8. J.S. Healey, S.J. Connolly, and M.R. Gold Subclinical atrial fibrillation and the risk of stroke N Engl J Med 366 2012 120 129
9. T.V. Glotzer, A.S. Hellkamp, and J. Zimmerman Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the atrial diagnostics ancillary study of the Mode Selection Trial (MOST) Circulation 107 2003 1614 1619
10. G.L. Botto, L. Padeletti, and M. Santini Presence and duration of atrial fibrillation detected by continuous monitoring: crucial implications for the risk of thromboembolic events J Cardiovasc Electrophysiol 20 2009 241 248
11. T.V. Glotzer, E.G. Daoud, D.G. Wyse, D.E. Singer, M.D. Ezekowitz, C. Hilker, C. Miller, D. Qi, and P.D. Ziegler The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study Circ Arrhythm Electrophysiol 2 2009 474 480
12. 2VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring Stroke 42 2011 1768 1770
13. G. Boriani, T.V. Glotzer, M. Santini, T.M. West, M. DeMelis, M. Sepsi, M. Gasparini, T. Lewalter, J.A. Camm, and D.E. Singer Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke prevention Strategies based on Atrial Fibrillation information from implanted devices) Eur Heart J 35 2014 508 516
14. S. Mittal, K. Stein, F.R. Gilliam III, S.M. Kraus, T.E. Meyer, and S.A. Christman Frequency, duration, and predictors of newly-diagnosed atrial fibrillation following dual-chamber pacemaker implantation in patients without a previous history of atrial fibrillation Am J Cardiol 102 2008 450 453
15. V. Fuster, L.E. Ryden, and D.S. Cannom ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for practice guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation):: developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Circulation 114 2006 e257 e354
16. M. Naito, D. David, E.L. Michelson, M. Schaffenburg, and L.S. Dreifus The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model Am Heart J 106 1983 284 291
17. M. Grogan, H.C. Smith, B.J. Gersh, and D.L. Wood Left ventricular dysfunction due to atrial fibrillation in patients initially believed to have idiopathic dilated cardiomyopathy Am J Cardiol 69 1992 1570 1573
18. D.L. Dries, D.V. Exner, B.J. Gersh, M.J. Domanski, M.A. Waclawiw, and L.W. Stevenson Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left Ventricular Dysfunction J Am Coll Cardiol 32 1998 695 703
19. M.J. Mihm, F. Yu, C.A. Carnes, P.J. Reiser, P.M. McCarthy, D.R. Van Wagoner, and J.A. Bauer Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation Circulation 104 2001 174 180
20. Y.M. Kim, T.J. Guzik, Y.H. Zhang, M.H. Zhang, H. Kattach, C. Ratnatunga, R. Pillai, K.M. Channon, and B. Casadei A myocardial NOX2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation Circ Res 97 2005 629 636
21. H. Cai, Z. Li, A. Goette, F. Mera, C. Honeycutt, K. Feterik, J.N. Wilcox, S.C. Dudley Jr., D.G. Harrison, and J.J. Langberg Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke Circulation 106 2002 2854 2858
22. M.K. Chung, D.O. Martin, D. Sprecher, O. Wazni, A. Kanderian, C.A. Carnes, J.A. Bauer, P.J. Tchou, M.J. Niebauer, A. Natale, and D.R. Van Wagoner C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation Circulation 104 2001 2886 2891
23. R.J. Aviles, D.O. Martin, C. Apperson-Hansen, P.L. Houghtaling, P. Rautaharju, R.A. Kronmal, R.P. Tracy, D.R. Van Wagoner, B.M. Psaty, M.S. Lauer, and M.K. Chung Inflammation as a risk factor for atrial fibrillation Circulation 108 2003 3006 3010
24. Y. Guo, G.Y. Lip, and S. Apostolakis Inflammation in atrial fibrillation J Am Coll Cardiol 60 2012 2263 2270
25. M. Lainscak, N. Dagres, G.S. Filippatos, S.D. Anker, and D.T. Kremastinos Atrial fibrillation in chronic non-cardiac disease: where do we stand? Int J Cardiol 128 2008 311 315
26. D. Farmakis, J. Parissis, and G. Filippatos Insights into onco-cardiology: atrial fibrillation J Am Coll Cardiol 63 2014 945 953